Recall Register

Drug recall: Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted)…

Class II FDA enforcement event 77933. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Morton Grove Pharmaceuticals, Inc. started this drug recall on 10 Aug 2017. The firm address in the FDA record is in Morton Grove, IL. FDA put the recall in Class II. FDA event 77933 has 1 product record. The first FDA enforcement report date is 6 Sep 2017. The record gives the status Terminated, with the termination date 13 Sep 2018. 93 of the 343 drug events that started in 2017 have more product records. The median drug event of 2017 has 1 product record. The openFDA file has 343 drug events that started in 2017 and 288 that started in 2016.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA and Puerto Rico.

Recalling firm

Morton Grove Pharmaceuticals, Inc., Morton Grove, IL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 77933: product records
Recall numberProductQuantityClassStatusReport date
D-1125-2017Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufactured By: Cipla Ltd. at Medispray Laboratories Pvt. Ltd., Kundaim Goa, India; Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054, NDC 60432-065-00.7332 bottlesClass IITerminated6 Sep 2017

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2017
343
Share of these events in Class II
57%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
7

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 77933. https://recallregister.com/fda/ii/77933/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA and Puerto Rico.
What quantity of product is in FDA event 77933?
The FDA record gives this quantity: 7332 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2017 have the same class?
57% of the 343 drug events that started in 2017 are in Class II.